New program aims to help seniors kick the sleeping pill habit

NCT ID NCT06584513

Ongoing Disease control Sponsor: Insel Gruppe AG, University Hospital Bern Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This study tests a patient-centred program to help older adults (65+) reduce or stop using sleeping pills like benzodiazepines. The program includes a tapering plan, educational materials, and cognitive behavioural therapy tools. Researchers will track whether participants can cut back safely and improve their sleep quality.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioural intervention (tapering plan, educational materials, cognitive behavioural therapy elements)
What this could lead to: If successful, this could provide a safe, effective way for older adults to stop relying on sleeping pills, reducing fall risks and other side effects.
What could go wrong: This is a relatively small implementation study, not a large-scale trial. The intervention may not work for everyone, and some people may need to continue medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENZODIAZEPINES DEPRESCRIBING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parasomnias

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENZODIAZEPINES DEPRESCRIBING SLEEP PROBLEMS

Contacts and locations

Locations

Centre Hospitalier Universitaire CHU UCL Namur

Yvoir, 5530, Belgium
Department of General Internal Medicine, University Hospital Bern (Inselspital)

Bern, 3010, Switzerland
Institute of Psychiatry and Neurology

Warsaw, 02-957, Poland
National and Kapodistrian University of Athens

Athens, 10679, Greece
Oslo University Hospital

Nydalen, 4950, Norway
Universitat Autònoma de Barcelona

Barcelona, 08041, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.